SCHEMBL4479233

SCHEMBL4479233

O=C(O)c1ncon1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23113893 0.78 — —
SCHEMBL1832217 0.78 — —
SCHEMBL8458175 0.73 — —
SCHEMBL23266336 0.73 CES1 (0.37) —
SCHEMBL14152761 0.72 CES1 (0.36) —
SCHEMBL19065228 0.68 — —
SCHEMBL19691092 0.68 SMYD3 (0.43) —
SCHEMBL15515155 0.66 TP53 (0.46) —
SCHEMBL24922320 0.64 — —
SCHEMBL108190 0.61 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6951946-B2 Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates LEXICON PHARMACEUTICALS, INC. (US) 2005-10-04 — — US claimed
US-20040019215-A1 Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates LEXICON PHARMACEUTICALS, INC. 2004-01-29 — — US claimed
EP-0805816-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1997-11-12 — — EP claimed
US-20260138991-A1 SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES MOMA THERAPEUTICS INC (US) 2026-05-21 — — US disclosed
EP-4705298-A2 SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES Moma Therapeutics, Inc. (US) 2026-03-11 — — EP disclosed
US-12559508-B2 Semi-saturated bicyclic derivatives and related uses MOMA THERAPEUTICS, INC. (US) 2026-02-24 — — US disclosed
US-20250230171-A1 SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES MOMA THERAPEUTICS, INC. 2025-07-17 — — US disclosed
CN-115340536-B Amide compound containing 1,2, 4-oxadiazole and salt, preparation method and application thereof 华东理工大学 2024-12-10 — — CN disclosed
US-20240368114-A1 INDAZOLES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX INC (US) 2024-11-07 — — US disclosed
WO-2024211836-A2 SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES MOMA THERAPEUTICS, INC. (US) 2024-10-10 — — WO disclosed
EP-3833672-B1 TRICYCLIC INHIBITORS OF HEPATITIS B VIRUS OSPEDALE SAN RAFFAELE SRL (IT) 2024-09-18 — — EP disclosed
EP-1487828-B1 MORPHOLINYL-UREA DERIVATIVES FOR USE OF THE TREATMENT OF INFLAMATORY DISEASES GLAXO GROUP LTD (GB) 2008-11-05 — — EP disclosed
US-20060063765-A1 Novel compounds GLAXO GROUP LIMITED (GB) 2006-03-23 — — US disclosed
US-6951946-B2 Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates LEXICON PHARMACEUTICALS, INC. (US) 2005-10-04 — — US disclosed
US-20050154211-A1 Large scale synthesis of 1,2,4- and 1,3,4- oxadiazole carboxylates KOLB HARTMUTH C (US) 2005-07-14 — — US disclosed
US-20040019215-A1 Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates LEXICON PHARMACEUTICALS, INC. 2004-01-29 — — US disclosed
EP-0647635-B1 Herbicidal 1,2,4-oxadiazolecarboxylic acids amides, esters or halides SHELL INT RESEARCH (NL) 1998-07-08 — — EP disclosed
EP-0647635-A1 Herbicidal 1,2,4-oxadiazolecarboxylic acids amides, esters or halides SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1995-04-12 — — EP disclosed
US-4159336-A ANTIALLERGENS THE UPJOHN COMPANY (US) 1979-06-26 — — US disclosed
US-4069332-A 5,5'-PHENYLENEBIS(1,2,4-OXADIAZOLE-3-CARBOXYLIC ACIDS OR ESTERS) THE UPJOHN COMPANY (US) 1978-01-17 — — US disclosed
Send feedback